Since 2007 a randomized clinical trial in the UK (the so-called PATCH trial) has been comparing the effectiveness and safety of transdermal estradiol patches to implants of an LHRH receptor agonist (goserelin acetate) in the treatment of advanced prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, agonist, androgen, deprivation, estradiol, LHRH, outcome, PATCH | Leave a comment »
On his Advanced Prostate Cancer blog site, Joel Nowak has just published a series of five brief articles on the opportunities offered by some older agents that are available for use as second-line therapies in the management of patients who have a rising PSA after treatment with standard forms of androgen deprivation therapy (ADT). … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management | Tagged: advanced, castration-resistant, CRPC, estradiol, GM-CSF, ketoconazole, octreotide | 3 Comments »
Today’s news reports summarize papers recently published on:
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: "high risk", estradiol, hormone therapy, HRQOL, optimism, outcomes, paclitaxel, pessimism, quality of life, radiation, radical prostatectomy | Leave a comment »
Today’s prostate cancer news reports cover items on:
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: Actonel, brachytherapy, cryotherapy, estradiol, Gleason score, outcome, permanent, quality of life, risedronate, seed, survey | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 